A 90 day old boy presented with frequent breathing difficulties and was found to have hypotonia in the lower limbs, inability to withdraw from painful stimuli, and sluggish deep reflexes. Based on these findings and the rare occurrence, he was diagnosed with spinal muscular atrophy with respiratory distress type 1 (SMARD1), a genetic motor neuron disorder characterized by diaphragmatic weakness, distal muscle atrophy, and autonomic dysfunction. Genetic testing confirmed the diagnosis of SMARD1, which is caused by mutations in the IGHMBP2 gene and accounts for approximately 1% of spinal muscular atrophy cases. Current availability of genetic testing allows for more accurate diagnosis and management of life-limiting genetic disorders like SM